Bacterial biofilms have attracted significant attention due to their involvement in persistent
infections, food and water contamination, and infrastructure corrosion. This review delves …

Bacterial infections in wounds significantly impair the healing process. The use of natural
antibacterial products over synthetic antibiotics has emerged as a new trend to address …

Cutaneous Leishmaniasis (CL) is a tropical disease characterized by cutaneous ulcers,
sometimes with satellite lesions and nodular lymphangitis. Leishmania parasites …

Cutaneous leishmaniasis (CL) lesions are chronic and result in disfiguring scars. The
microbiological aspects of these wounds have not been systematically investigated. We …

Cutaneous leishmaniasis (CL) is the most common form of the disease which can cause
malignant lesions on the skin. Vaccination for the prevention and treatment of leishmaniasis …

Leishmania braziliensis is a parasitic infection that can result in inflammation and skin injury
with highly variable and unpredictable clinical outcomes. Here, we investigated the potential …

The accessibility of sterols in mammalian cells to exogenous sterol-binding agents has been
well-described previously, but sterol accessibility in distantly related protozoa is unclear. The …

Visceral leishmaniasis (VL), a vector-borne parasitic disease caused by Leishmania
donovani and L. infantum (Kinetoplastida), affects humans and dogs, being fatal unless …

Cutaneous Leishmaniasis (CL) affects millions of people globally and has a significant
impact on morbidity and mortality. Innate immune mediators are likely to influence the …

Nephrotoxicity is one common side effect of the first line anti-leishmanial treatment,
liposomal amphotericin B. Amphotericin B targets ergosterol, so one approach to reducing …